Figures & data
Table 1 Characteristics of COVID-19-Positive CARE Registry Participants at Enrollment by Self-Reported Use of Medications for Autoimmune Disease
Figure 1 Symptom prevalence (%) for COVID-19-positive participants by self-reported use of medication for autoimmune disease.
![Figure 1 Symptom prevalence (%) for COVID-19-positive participants by self-reported use of medication for autoimmune disease.](/cms/asset/be3fbd90-db1d-4386-84e4-12a733e6455e/dijg_a_12168084_f0001_c.jpg)
Table 2 Risk of More Severe COVID-19 Presentation and Persistent Symptoms Among Participants Reporting Use of Medications for Autoimmune Disease Compared to Those Reporting Not Taking Medications
Table 3 Distribution of Symptoms at Enrollment and Follow-Up by Use of Medications for Autoimmune Disease